Mustang Bio prelim Q1 cash $1.3M, operating burn $5.3M, cash runway concerns

MUSTANG BIO, INC.

Preliminary cash and equivalents as of March 31, 2024: approximately $1.3 million.
Cash used in operating activities for Q1 2024: approximately $5.3 million.
Results are preliminary and subject to completion of closing procedures; actual results may differ.
Company cautions not to place undue reliance on these estimates.

item 2.02

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

MUSTANG BIO, INC. reported preliminary financial results for the three months ended March 31, 2024.

Period: the three months ended March 31, 2024
Result: preliminary results

Exact text from the filing

Based on information currently available, we estimate that as of March 31, 2024, cash and cash equivalents were approximately $1.3 million, and cash used in operating activities for the first quarter of 2024 was $5.3 million.

View on SEC.gov

201 earnings releases filed in the last 30 days. Browse all earnings releases →

MUSTANG BIO, INC. filing history →

Source: SEC EDGAR

accession 0001104659-24-053706

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.